Shire subsidiaries settled litigation with Actavis and Watson Laboratories

Pharmaceuticals group Shire has said its subsidiary Shire LLC, has settled all pending litigation with Actavis and Watson Laboratories.

Pharmaceuticals group Shire has said its subsidiary Shire LLC, has settled all pending litigation with Actavis and Watson Laboratories.

The litigation was in relation Actavis and Watson's abbreviated new drug applications (ANDAs) for generic versions of Shire's Intuniv product for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

The settlement provides Actavis with a licence to make and market its generic versions of Intuniv in the US on December 1st 2014, and any sales will results in royalty payments of 25% of gross profits to Shire during the 180 day exclusivity period.

The settlement also provides Watson with a licence to make and market Watson's generic versions of Intuniv in the US 181 days after Actacis's own launch.

NR

Recommended

Broker safety – your questions answered
Investment strategy

Broker safety – your questions answered

Cris Sholto Heaton answers more of your questions about the safety of stockbroker accounts
25 Mar 2020
How demographics affects stock valuations
Investment strategy

How demographics affects stock valuations

New research suggests that stock and bond valuations are driven by the age of the population – at least in the US.
24 Feb 2020
Do you own shares in Sirius Minerals? Here’s what you need to do now
Stocks and shares

Do you own shares in Sirius Minerals? Here’s what you need to do now

Mining giant Anglo American has proposed a cash takeover of Yorkshire-based minnow Sirius Minerals. Unhappy shareholders must decide whether to accept…
20 Feb 2020
Why investors should be “cautiously bullish” for 2020
Stockmarkets

Why investors should be “cautiously bullish” for 2020

Analysts have been out in force making rosy predictions for stockmarkets in 2020, but while there is certainly a case for optimism, investors should r…
17 Jan 2020

Most Popular

Will a second wave of Covid lead to another stockmarket crash?
Stockmarkets

Will a second wave of Covid lead to another stockmarket crash?

Can we expect to see another lockdown like in March, and what will that mean for your money? John Stepek explains.
18 Sep 2020
IAG's share price is ready for take-off - here's how to play it
Trading

IAG's share price is ready for take-off - here's how to play it

The owner of British Airways has had a turbulent year, but is now worth a punt. Matthew Partridge explains the best way to play it.
8 Sep 2020
Here’s why you really should own at least some bitcoin
Bitcoin

Here’s why you really should own at least some bitcoin

While bitcoin is having a quiet year – at least in relative terms – its potential to become the default cash system for the internet is undiminished, …
16 Sep 2020